Codexis to Participate in Upcoming Healthcare Conferences

Codexis to Participate in Upcoming Healthcare Conferences

REDWOOD CITY, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that management will participate in four upcoming investor conferences.

The Stifel 2024 Healthcare Conference (New York, NY)

• Monday, November 18, 2024, at 2:25 pm ET, management will participate in a fireside chat
  

The Jefferies London Healthcare Conference (London, UK)

• Tuesday, November 19, 2024, at 9:30 am GMT, management will participate in a fireside chat
  

The 15^th Annual Craig-Hallum Alpha Select Conference (New York, NY)

• Tuesday, November 19, 2024, management will host 1x1 investor meetings
  

The Stephens Annual Investment Conference (Nashville, TN)

• Thursday, November 21, 2024, at 12:00 pm CT, management will participate in a fireside chat
  

Live webcasts of each fireside chat will be available on the Investor Relations section of the Company's website, https://ir.codexis.com. A replay of each fireside chat will be archived for 90 days following the presentation date.

About Codexis

Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver^® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.

For More Information

Investor Contact
Carrie McKim
(336) 608-9706
[email protected]

Media Contact
Lauren Musto
(650) 421-8205
[email protected]

Source: Codexis, Inc.

Released November 4, 2024

Public link

Please use the above public link if you want to share this noodl on another website.